Tower Research Capital LLC (Trc) Bio Affinity Technologies, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,085 shares of BIAF stock, worth $2,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,085
Previous 4,615
54.82%
Holding current value
$2,460
Previous $9,000
55.56%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BIAF
# of Institutions
15Shares Held
468KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$307,8250.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.2KShares$102,8730.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$32,9040.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC20KShares$23,6000.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$20,7680.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $3.22M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...